These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28705672)

  • 1. Role of vancomycin in the treatment of bacteraemia and meningitis caused by Elizabethkingia meningoseptica.
    Jean SS; Hsieh TC; Ning YZ; Hsueh PR
    Int J Antimicrob Agents; 2017 Oct; 50(4):507-511. PubMed ID: 28705672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early neonatal sepsis and meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia.
    Barnawi AI; Kordy FN; Almuwallad OK; Kassarah KA
    Saudi Med J; 2020 Jul; 41(7):753-756. PubMed ID: 32601645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Elizabethkingia meningoseptica Neonatal Meningitis with Combination Systemic and Intraventricular Therapy.
    Joshi P; Shah B; Joshi V; Kumar A; Singhal T
    Indian J Pediatr; 2019 Apr; 86(4):379-381. PubMed ID: 30790188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections.
    Jean SS; Lee WS; Chen FL; Ou TY; Hsueh PR
    J Hosp Infect; 2014 Apr; 86(4):244-9. PubMed ID: 24680187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Management of Elizabethkingia meningoseptica Meningitis with Intraventricular Vancomycin.
    Soman R; Agrawal U; Suthar M; Desai K; Shetty A
    J Assoc Physicians India; 2016 Oct; 64(10):98-99. PubMed ID: 27766817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult.
    Neuner EA; Ahrens CL; Groszek JJ; Isada C; Vogelbaum MA; Fissell WH; Bhimraj A
    J Antimicrob Chemother; 2012 Jun; 67(6):1558-60. PubMed ID: 22357803
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia.
    Amer MZ; Bandey M; Bukhari A; Nemenqani D
    J Infect Dev Ctries; 2011 Oct; 5(10):745-7. PubMed ID: 21997946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole treatment for meningitis owing to multidrug-resistant Elizabethkingia meningoseptica in an extremely low-birthweight, premature infant.
    Gokce IK; Oncel MY; Ozdemir R; Erdeve O; Oguz SS; Canpolat FE; Uras N; Dilmen U
    Paediatr Int Child Health; 2012 Aug; 32(3):177-9. PubMed ID: 22824670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia.
    Huang YC; Lin YT; Wang FD
    Int J Antimicrob Agents; 2018 Jan; 51(1):47-51. PubMed ID: 28668676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outbreak of Elizabethkingia meningoseptica neonatal meningitis in Mauritius.
    Issack MI; Neetoo Y
    J Infect Dev Ctries; 2011 Dec; 5(12):834-9. PubMed ID: 22169781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.
    Chang TY; Chen HY; Chou YC; Cheng YH; Sun JR
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2045-2052. PubMed ID: 31352669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone.
    Chan JC; Chong CY; Thoon KC; Tee NWS; Maiwald M; Lam JCM; Bhattacharya R; Chandran S; Yung CF; Tan NWH
    J Med Microbiol; 2019 Aug; 68(8):1167-1172. PubMed ID: 31199227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of Elizabethkingia meningoseptica sepsis with meningitis in a well-baby nursery.
    Tai IC; Liu TP; Chen YJ; Lien RI; Lee CY; Huang YC
    J Hosp Infect; 2017 Jun; 96(2):168-171. PubMed ID: 28077242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Elizabethkingia meningosepticum bacteremia in a patient with Bardet-Biedl syndrome and chronic renal failure].
    Bayrak B; Fıncanci M; Bınay UD; Çımen C; Özkantar Ünlügüneş GU
    Mikrobiyol Bul; 2014 Jul; 48(3):495-500. PubMed ID: 25052117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elizabethkingia anophelis Infection in Infants, Cambodia, 2012-2018.
    Reed TAN; Watson G; Kheng C; Tan P; Roberts T; Ling CL; Miliya T; Turner P
    Emerg Infect Dis; 2020 Feb; 26(2):320-322. PubMed ID: 31961289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Prevalence and Antimicrobial Susceptibility of Clinical Isolates of Elizabethkingia Species Based on 16S rRNA Gene Sequencing.
    Han MS; Kim H; Lee Y; Kim M; Ku NS; Choi JY; Yong D; Jeong SH; Lee K; Chong Y
    J Clin Microbiol; 2017 Jan; 55(1):274-280. PubMed ID: 27847376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mini review: New pathogen profiles: Elizabethkingia anophelis.
    Janda JM; Lopez DL
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):201-205. PubMed ID: 28342565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.
    Huang YC; Huang YW; Lin YT; Wang FD; Chan YJ; Yang TC
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1373-1380. PubMed ID: 28265817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
    Chen CH; Lin CH; Lin JS
    Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e26. PubMed ID: 28591254
    [No Abstract]   [Full Text] [Related]  

  • 20. Case Series and Mini-Review on Elizabethkingia meningoseptica, A high Alert Organism Causing Meningitis in Premature Neonates from A Tertiary Care Hospital of Western Rajasthan.
    Abhishek KS; Kombade SP; Gupta N; Tak V; Nag VL; Singh K; Agarwal N
    Infect Disord Drug Targets; 2021; 21(8):e160921189884. PubMed ID: 33397245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.